[HTML][HTML] A genetic model for muscle–eye–brain disease in mice lacking protein O-mannose 1, 2-N-acetylglucosaminyltransferase (POMGnT1)
J Liu, SL Ball, Y Yang, P Mei, L Zhang, H Shi… - Mechanisms of …, 2006 - Elsevier
J Liu, SL Ball, Y Yang, P Mei, L Zhang, H Shi, HJ Kaminski, VP Lemmon, H Hu
Mechanisms of development, 2006•ElsevierProtein O-mannose β1, 2-N-acetyglucosaminyltransferase 1 (POMGnT1) is an enzyme
involved in the synthesis of O-mannosyl glycans. Mutations of POMGnT1 in humans result in
the muscle–eye–brain (MEB) disease. In this study, we have characterized a null mutation
generated by gene trapping with a retroviral vector inserted into the second exon of the
mouse POMGnT1 locus. Expression of POMGnT1 mRNA was abolished in mutant mice.
Glycosylation of α-dystroglycan was also reduced. POMGnT1 mutant mice were viable with …
involved in the synthesis of O-mannosyl glycans. Mutations of POMGnT1 in humans result in
the muscle–eye–brain (MEB) disease. In this study, we have characterized a null mutation
generated by gene trapping with a retroviral vector inserted into the second exon of the
mouse POMGnT1 locus. Expression of POMGnT1 mRNA was abolished in mutant mice.
Glycosylation of α-dystroglycan was also reduced. POMGnT1 mutant mice were viable with …
Protein O-mannose β1,2-N-acetyglucosaminyltransferase 1 (POMGnT1) is an enzyme involved in the synthesis of O-mannosyl glycans. Mutations of POMGnT1 in humans result in the muscle–eye–brain (MEB) disease. In this study, we have characterized a null mutation generated by gene trapping with a retroviral vector inserted into the second exon of the mouse POMGnT1 locus. Expression of POMGnT1 mRNA was abolished in mutant mice. Glycosylation of α-dystroglycan was also reduced. POMGnT1 mutant mice were viable with multiple developmental defects in muscle, eye, and brain, similar to the phenotypes observed in human MEB disease. The present study provides the first genetic animal model to further dissect the roles of POMGnT1 in MEB disease.
Elsevier